Omega-3 Fatty Acids: A novel approach for pain treatment
2nd International Conference on Central Nervous System and Therapeutics
June 10-11, 2019 | Edinburgh, Scotland
Carlos Laino
National University of La Rioja, Argentina
Posters & Accepted Abstracts : J Neurol Neurorehabil Res
Abstract:
The treatment of acute and chronic severe pain remains an
important common challenge faced by clinicians working
with the general population, and even after applying recent
advances in the treatment of acute and chronic severe pain,
there can continue to be manifestations of adverse effects.
Chronic pain affects many aspects in the life of the patient,
and often has an impact on their families. In some cases,
after an acute pain, the patient continues to experience
chronic pain, which can be a result of illnesses such as cancer.
As there is growing evidence that omega-3 fatty acids can
contribute to the reduction of pain, this presentation will
describe an innovative technological development, both in its
pharmaceutical composition (using omega-3 fatty acids with
either morphine or methadone) and in the pharmacological
treatments associated with its use. In addition, the preclinical
evidence concerning the analgesic effects of omega-3 fatty
acids (eicosapentaenoic acid and docosahexaenoic acid) will
also be explored.
The main advantage of new pharmacological treatments
using these pharmaceutical compositions lies in the improved
pain control obtained with a sub-therapeutic dose of these
opioids, which can lead to the elimination or at least potential
reduction of the adverse effects.
Biography:
E-mail :
carloslaino25@gmail.comPDF HTML